Tong‐Fei Li

1.2k total citations
44 papers, 882 citations indexed

About

Tong‐Fei Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Biomedical Engineering. According to data from OpenAlex, Tong‐Fei Li has authored 44 papers receiving a total of 882 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 17 papers in Pulmonary and Respiratory Medicine and 16 papers in Biomedical Engineering. Recurrent topics in Tong‐Fei Li's work include Nanoplatforms for cancer theranostics (15 papers), Photodynamic Therapy Research Studies (10 papers) and Immune cells in cancer (8 papers). Tong‐Fei Li is often cited by papers focused on Nanoplatforms for cancer theranostics (15 papers), Photodynamic Therapy Research Studies (10 papers) and Immune cells in cancer (8 papers). Tong‐Fei Li collaborates with scholars based in China, Japan and United States. Tong‐Fei Li's co-authors include Xiao Chen, Hua‐Zhen Xu, Liu‐Gen Li, Ning Han, Xing‐Chun Peng, Tingting Yu, Yong‐Hong Xu, Li Zhao, Xiang Xu and Qi‐Rui Li and has published in prestigious journals such as ACS Nano, Biomaterials and Scientific Reports.

In The Last Decade

Tong‐Fei Li

39 papers receiving 877 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tong‐Fei Li China 17 408 327 263 212 177 44 882
Weimin Yin China 16 499 1.2× 357 1.1× 136 0.5× 272 1.3× 260 1.5× 33 1.0k
Lingpu Zhang China 13 373 0.9× 273 0.8× 145 0.6× 161 0.8× 148 0.8× 24 756
Jianhao Lai China 11 609 1.5× 261 0.8× 213 0.8× 251 1.2× 170 1.0× 18 1.0k
Di Jing China 14 332 0.8× 319 1.0× 149 0.6× 78 0.4× 270 1.5× 35 780
Tingsheng Lin China 18 454 1.1× 281 0.9× 212 0.8× 82 0.4× 174 1.0× 26 1.0k
Rongying Zhu China 15 460 1.1× 409 1.3× 152 0.6× 85 0.4× 305 1.7× 34 1.0k
Binfan Chen China 12 470 1.2× 340 1.0× 101 0.4× 362 1.7× 272 1.5× 14 913
Yangyang Du China 15 437 1.1× 462 1.4× 148 0.6× 178 0.8× 174 1.0× 24 920
Boshu Ouyang China 11 519 1.3× 315 1.0× 251 1.0× 124 0.6× 262 1.5× 17 823
Huihai Zhong China 16 536 1.3× 320 1.0× 128 0.5× 245 1.2× 217 1.2× 21 887

Countries citing papers authored by Tong‐Fei Li

Since Specialization
Citations

This map shows the geographic impact of Tong‐Fei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tong‐Fei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tong‐Fei Li more than expected).

Fields of papers citing papers by Tong‐Fei Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tong‐Fei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tong‐Fei Li. The network helps show where Tong‐Fei Li may publish in the future.

Co-authorship network of co-authors of Tong‐Fei Li

This figure shows the co-authorship network connecting the top 25 collaborators of Tong‐Fei Li. A scholar is included among the top collaborators of Tong‐Fei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tong‐Fei Li. Tong‐Fei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Liu‐Gen, Hao Chen, Tingting Yu, et al.. (2025). Suppression of NRF2 by photodynamic action to enhance bortezomib-triggered DNA damage for synergistic colorectal cancer therapy. Journal of Photochemistry and Photobiology B Biology. 267. 113162–113162.
3.
Zhao, Junjie, Jin‐Jian Lu, Xing‐Chun Peng, et al.. (2025). Cepharanthine Loaded TCPP‐MOF Triggers Pyroptosis Through TSPO Inhibition for Hepatocellular Carcinoma Sonodynamic‐Chemotherapy. Advanced Healthcare Materials. 14(23). e2500630–e2500630.
4.
Li, Tong‐Fei, et al.. (2025). Challenges and Opportunities: Nanomaterials in Epilepsy Diagnosis. ACS Nano. 19(17). 16224–16247. 3 indexed citations
5.
Liu, Jie, et al.. (2025). Recent progress in polysaccharide microsphere-based hemostatic material for intravascular and extravascular hemostasis: A review. International Journal of Biological Macromolecules. 300. 140280–140280. 5 indexed citations
6.
Li, Xianyu, Dapeng Ding, Xing Zhao, et al.. (2025). Accelerated differentiation of photothermal effect-induced mesenchymal stem cells regulated by activating HSP90-autophagy boosts wound repair. International Journal of Pharmaceutics. 676. 125631–125631.
7.
Xiao, Chengbo, Yijun Tang, Cunqing Kong, et al.. (2024). Treatment of silicosis with quercetin depolarizing macrophages via inhibition of mitochondrial damage-associated pyroptosis. Ecotoxicology and Environmental Safety. 286. 117161–117161. 2 indexed citations
8.
Bai, Xiaofeng, Meifang Wang, Liu‐Gen Li, et al.. (2024). Cepharanthine triggers ferroptosis through inhibition of NRF2 for robust ER stress against lung cancer. European Journal of Pharmacology. 979. 176839–176839. 8 indexed citations
9.
Li, Tong‐Fei, Zhijie Xu, Kui Zhang, et al.. (2024). Effects and mechanisms of N6-methyladenosine RNA methylation in environmental pollutant-induced carcinogenesis. Ecotoxicology and Environmental Safety. 277. 116372–116372. 4 indexed citations
10.
Li, Liu‐Gen, Xing‐Chun Peng, Ziyi Yang, et al.. (2024). Dihydroartemisinin-driven selective anti-lung cancer proliferation by binding to EGFR and inhibition of NRAS signaling pathway-induced DNA damage. Scientific Reports. 14(1). 11704–11704. 3 indexed citations
11.
Chen, Nannan, Liu‐Gen Li, Tingting Yu, et al.. (2024). Cepharanthine-mediated endoplasmic reticulum stress inhibits Notch1 via binding GRP78 for suppressing hepatocellular carcinoma metastasis. Phytomedicine. 135. 156162–156162. 5 indexed citations
12.
Xu, Zhijie, Zhiyang Zhou, Xiaoxin Yang, et al.. (2024). Determining M2 macrophages content for the anti-tumor effects of metal-organic framework-encapsulated pazopanib nanoparticles in breast cancer. Journal of Nanobiotechnology. 22(1). 429–429. 9 indexed citations
13.
Chen, Hao, Xing‐Chun Peng, Liu‐Gen Li, et al.. (2023). Up-regulation of ABCG2 by MYBL2 deletion drives Chlorin e6-mediated photodynamic therapy resistance in colorectal cancer. Photodiagnosis and Photodynamic Therapy. 42. 103558–103558. 8 indexed citations
14.
Yan, Yuanliang, Xiaoxin Yang, Ning Han, et al.. (2023). Metal-organic framework-encapsulated dihydroartemisinin nanoparticles induces apoptotic cell death in ovarian cancer by blocking ROMO1-mediated ROS production. Journal of Nanobiotechnology. 21(1). 204–204. 22 indexed citations
15.
Han, Ning, Ziyi Yang, Hua‐Zhen Xu, et al.. (2023). Dihydroartemisinin elicits immunogenic death through ferroptosis-triggered ER stress and DNA damage for lung cancer immunotherapy. Phytomedicine. 112. 154682–154682. 51 indexed citations
16.
Chen, Nannan, Qi‐Rui Li, Jun Hu, et al.. (2023). Indocyanine green-loaded platelet activated by photodynamic and photothermal effects for selective control of wound repair. Photodiagnosis and Photodynamic Therapy. 45. 103945–103945. 3 indexed citations
17.
Yu, Tingting, Ning Han, Liu‐Gen Li, et al.. (2022). Chlorin e6-Induced Photodynamic Effect Polarizes the Macrophage Into an M1 Phenotype Through Oxidative DNA Damage and Activation of STING. Frontiers in Pharmacology. 13. 837784–837784. 15 indexed citations
18.
Han, Ning, Liu‐Gen Li, Xing‐Chun Peng, et al.. (2022). Ferroptosis triggered by dihydroartemisinin facilitates chlorin e6 induced photodynamic therapy against lung cancer through inhibiting GPX4 and enhancing ROS. European Journal of Pharmacology. 919. 174797–174797. 49 indexed citations
19.
Yu, Tingting, Ning Han, Xing‐Chun Peng, et al.. (2021). Macrophages mediated delivery of chlorin e6 and treatment of lung cancer by photodynamic reprogramming. International Immunopharmacology. 100. 108164–108164. 17 indexed citations
20.
Li, Tong‐Fei, Ke Li, Chao Wang, et al.. (2017). Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment. Journal of Controlled Release. 268. 128–146. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026